KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial

NCT05882305 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No Participants Enrolled

Conditions

EBV-associated Lymphomas

Interventions

BIOLOGICAL: Autologous monocyte-derived DCs pulsed withEBV-associated antigen

Sponsor

Kousai Bio Co., Ltd.